Latest news

Patient-Centric Clinical Trials And The Role Of A Travel Concierge

Many people find booking plane tickets, arranging road transportation and overnight lodging overwhelming. Add into that mix...

China forces insulin price cuts resulting in pullback for global pharma players

Xinhua, a Chinese news channel, commented on the price cut on insulin which was brought on by...

Aussie pharma CSL in talks to buy Swiss firm Vifor Pharma for USD 7B

CSL, the Australian giant, is in talks to buy Vifor Pharma in a deal that is valued...

Sanofi to acquire Origimm Biotechnology in a bid to expand vaccine pipeline

Sanofi will acquire Origimm Biotechnology as per an agreement signed by the two healthcare companies. The deal...

Moberg Pharma joins hands with Allderma to market nail fungus product in Scandinavia

Moberg pharma joins hands with Allderma to enter the market with a new nail fungus product named...

Bayer Raises Enthusiasm about Kerendia Heart and Kidney Disease Drug after SGLT2 Patients see Benefits

It was previously thought that the heart and kidney disease drug Kerendia, was in competition with SGLT2...

Three ways Unified Communications Solutions are Changing the Pharmaceutical and Biotech Industries

If we’ve learned one thing during the COVID-19 pandemic. It’s that when faced with adversity. We can...

Vaccine Hesitancy on the Rise: Here’s Why Vaccine Clinical Trial Process Have Never Been Safer

It’s been a little over one year since the U.S. Food and Drug Administration (FDA) approved the...

Superbugs Could Be the Next Pandemic: We Need a Global, Comprehensive Plan to Address Them Now!

COVID-19 is clearly a generation-defining public health crisis; one which could have a lasting impact on many facets of our lives for many years to come.

Renewed Drug-Pricing Plan by White House Looms over Biotech and Pharma Industry

The White House is all set to announce a price reduction plan for prescription drugs and the...

Gilead, Merck and other big pharmas engaged in illicit “pay-for-delay” deals to retain their lucrative HIV and cholesterol meds supremacy

Gilead and Merck, along with some other renowned pharmaceutical companies, are involved in “pay-for-delay” deals to settle...

Astellas Pharma’s Fezolinetant Trials Show Positive Results in Reducing Vasomotor Symptoms

For the treatment of moderate to severe Vasomotor Symptoms (VMS) in post-menopausal women, Astellas’ Fezolinetant, has shown...

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

In the middle of the debate about the Alzheimer’s drug approval, the United States FDA has authorized Aduhelm

Popular

Most popular life news you must read today

NRx Pharma’s ZYESAMI™ approved for emergency use Covid critical care in Georgia

As of July 27, a global biopharmaceutical company, NRx Pharmaceuticals, has announced that the Prime Minister of the Nation of Georgia

Eton Pharma gets FDA nod on Rezipres® for treatment of hypotension in anesthesia settings

Rezipres, an ephedrine HCL (hydrochloride) injectable manufactured by Eton Pharmaceuticals, has been approved by FDA to treat

Vertex scores FDA nod for kids’ cystic fibrosis drug Trikafta

Trikafta was approved by FDA for the treatment of Cystic Fibrosis in patients aged 6 to 11 years, after receiving approval to be used in patients of ages 12 and up

Commercial

Moberg Pharma joins hands with Allderma to market nail fungus product in Scandinavia

Moberg pharma joins hands with Allderma to enter the market with a new nail fungus product named...

U.S. to buy additional $1B of Merck’s Covid-19 drug

In the latest Merck’s COVID-19 news, it was reported that President Biden’s government has plans to place...

Merck acquires Acceleron Pharma for $11.5B to expand cardiovascular pipeline

To aid the growth of its expanding cardiovascular treatments pipeline, Merck is striking an acquisition deal worth...

Renewed Drug-Pricing Plan by White House Looms over Biotech and Pharma Industry

The White House is all set to announce a price reduction plan for prescription drugs and the...

Gilead, Merck and other big pharmas engaged in illicit “pay-for-delay” deals to retain their lucrative HIV and cholesterol meds supremacy

Gilead and Merck, along with some other renowned pharmaceutical companies, are involved in “pay-for-delay” deals to settle...

Amarin goes from conventional to digital marketing for its icosapent ethyl drug VASCEPA

Amarin, an Irish-American biopharmaceutical company, revealed last week that the company is going to downsize its sales...

Information Technology

Softbank now has $5B stake in Roche for its ability to develop drugs using data

The Japanese multinational group, SoftBank Group Corp., has quietly invested $5 billion...

Most life sciences executives say digital delivery of drugs is the future of health

The world’s leading connectivity and provider of electronic solutions, Molex and, its medical device distribution subsidiary, Phillips-Mediaize,

Eli Lilly is most innovative while Bristol Myers Squibb has the best pipeline in annual IDEA Pharma study

Eli Lilly is ranked first in the industry for the very first time in the 10th annual addition of the Pharmaceutical Innovation Index.

Qualitest continues growth trajectory, acquires Comply to expand Pharma and Digital Health footprint

Qualitest, one of the world's leading AI-powered, engineering-driven software testing and quality assurance companies

Regulatory

Walgreens is changing Pfizer second dose COVID-19 vaccine timing based on CDC recommendation

Until now, Walgreens had been administering the second dose of the Pfizer vaccine four weeks after the first

China forces insulin price cuts resulting in pullback for global pharma players

Xinhua, a Chinese news channel, commented on...

Aussie pharma CSL in talks to buy Swiss firm Vifor Pharma for USD 7B

CSL, the Australian giant, is in talks...

Sanofi to acquire Origimm Biotechnology in a bid to expand vaccine pipeline

Sanofi will acquire Origimm Biotechnology as per...
- Advertisement -

Research & Development

Mekonos closes $25M funding round for cell therapy platform

Mekonos closes funding of $25M in a series a round as it...

Superbugs Could Be the Next Pandemic: We Need a Global, Comprehensive Plan to Address Them Now!

COVID-19 is clearly a generation-defining public health crisis; one which could have a lasting impact on many facets of our lives for many years to come.

AstraZeneca partners with Imperial’s VaxEquity to bolster its self-amplifying RNA based drugs pipeline

AstraZeneca has inked a deal with VaxEquity, a firm producing experimental COVID-19...

Chinese Pharma Companies Pushing for Global Reach with focus on R&D

In targeted therapies, drugs are used to “target” cancerous cells without having...

Market Access

Empower Pharmacy inaugurates a $55m facility in Houston

A compounding pharmacy, which is also FDA registered outsourcing facility, Empower Pharmacy,...

Pharma will produce over 12B Covid-19 vaccine doses by Dec and 24B by June

The International Federation of Pharmaceutical Manufacturers & Associations predicted that Covid-19 vaccine...

Hetero gets approval to make Roche’s tocilizumab in India under the brand name Tocira

By this month’s end, Hetero is planning on making tocilizumab in India...

Japan investigating if Moderna vaccine contamination caused death of three people

A day after his second dose of Moderna vaccine, a 49-year-old man...

API manufacturing to see a boom with increased FDA biologic approvals

Last year, a larger number of biologic New Molecular Entities(NMEs) were approved by the United States FDA (Food and Drug Administration) than in the past 10 years.

AstraZeneca and Aji Bio-Pharma Expand Mfg. Agreement

Ajinomoto Bio-Pharma Services, a provider of biopharmaceutical contract development and manufacturing services

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Patient-Centric Clinical Trials And The Role Of A Travel Concierge

Many people find booking plane tickets, arranging...

Pharma will produce over 12B Covid-19 vaccine doses by Dec and 24B by June

The International Federation of Pharmaceutical Manufacturers &...

Aussie pharma CSL in talks to buy Swiss firm Vifor Pharma for USD 7B

CSL, the Australian giant, is in talks...
Nominations for Top Industry Leaders Awards are now open!